# Sugammadex Reversal of Neuromuscular Blockade and Postoperative Bleeding

> **NCT02939430** · NA · UNKNOWN · sponsor: **Mansoura University** · enrollment: 40 (estimated)

## Conditions studied

- Blood Coagulation Tests ( INR, APTT)

## Interventions

- **DRUG:** Sugammadex intravenous
- **DRUG:** Intravenous neostigmine and atropine

## Key facts

- **NCT ID:** NCT02939430
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-11
- **Primary completion:** 2017-10
- **Final completion:** 2017-11
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2017-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02939430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02939430, "Sugammadex Reversal of Neuromuscular Blockade and Postoperative Bleeding". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02939430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*